ATE151076T1 - Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen - Google Patents

Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen

Info

Publication number
ATE151076T1
ATE151076T1 AT91110570T AT91110570T ATE151076T1 AT E151076 T1 ATE151076 T1 AT E151076T1 AT 91110570 T AT91110570 T AT 91110570T AT 91110570 T AT91110570 T AT 91110570T AT E151076 T1 ATE151076 T1 AT E151076T1
Authority
AT
Austria
Prior art keywords
terminals
internucleotide linkages
oligonucleotide analogues
linkages
analogues
Prior art date
Application number
AT91110570T
Other languages
German (de)
English (en)
Inventor
Hannelore Roesch
Anja Froehlich
Jose Flavio Ramalho-Ortigao
Matthias Prof Dr Montenarh
Hartmut Prof Dr Seliger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of ATE151076T1 publication Critical patent/ATE151076T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT91110570T 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen ATE151076T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02

Publications (1)

Publication Number Publication Date
ATE151076T1 true ATE151076T1 (de) 1997-04-15

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91110570T ATE151076T1 (de) 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen

Country Status (22)

Country Link
US (1) US5750669A (ko)
EP (1) EP0464638B1 (ko)
JP (1) JP3186795B2 (ko)
KR (1) KR100200400B1 (ko)
AT (1) ATE151076T1 (ko)
AU (1) AU647143B2 (ko)
CA (1) CA2045891C (ko)
CZ (1) CZ285408B6 (ko)
DE (1) DE59108644D1 (ko)
DK (1) DK0464638T3 (ko)
ES (1) ES2099718T3 (ko)
FI (1) FI104177B1 (ko)
GR (1) GR3023432T3 (ko)
HU (1) HU215147B (ko)
IE (1) IE912309A1 (ko)
IL (1) IL98672A (ko)
NO (1) NO303018B1 (ko)
NZ (1) NZ238769A (ko)
PT (1) PT98169B (ko)
SK (1) SK279544B6 (ko)
TW (1) TW206232B (ko)
ZA (1) ZA915056B (ko)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
ES2103408T3 (es) 1992-09-24 1997-09-16 Hoechst Ag Analogos de oligorribonucleotidos y ribozimas con uniones terminales en 3'-3' o 5'-5' respectivamente.
HU9501974D0 (en) * 1993-03-31 1995-09-28 Sterling Winthrop Inc Oligonucleotides with amide linkages replacing phosphodiester linkages
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) * 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) * 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
WO2001096357A2 (en) * 2000-06-13 2001-12-20 Proligo Llc Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
EP2292632A3 (en) * 2000-09-26 2012-07-25 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
US20040043950A1 (en) * 2002-01-03 2004-03-04 Board Of Regents, The University Of Texas System WT1 antisense oligos for the inhibition of breast cancer
JP2005526497A (ja) * 2002-02-04 2005-09-08 ビオミラ，インコーポレーテッド 免疫刺激性、共有結合性脂質化オリゴヌクレオチド
CA2504720C (en) 2002-11-05 2013-12-24 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
WO2004044136A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
AU2005252662B2 (en) * 2004-06-03 2011-08-18 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
CN109072223B (zh) * 2016-04-08 2022-10-21 川斯勒佰尔公司 多聚体编码核酸及其用途
US11603532B2 (en) 2017-06-02 2023-03-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
CN112004928A (zh) * 2018-04-12 2020-11-27 波涛生命科学有限公司 寡核苷酸组合物及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
WO1989009221A1 (en) * 1988-03-25 1989-10-05 University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
DK0464638T3 (da) 1997-10-13
CS201491A3 (en) 1992-01-15
IL98672A0 (en) 1992-07-15
NO912585L (no) 1992-01-03
EP0464638A3 (en) 1992-09-02
PT98169A (pt) 1993-09-30
KR920002625A (ko) 1992-02-28
EP0464638A2 (de) 1992-01-08
TW206232B (ko) 1993-05-21
SK279544B6 (sk) 1998-12-02
IL98672A (en) 1995-12-08
CA2045891A1 (en) 1992-01-03
CZ285408B6 (cs) 1999-08-11
FI104177B (fi) 1999-11-30
HU912215D0 (en) 1991-12-30
US5750669A (en) 1998-05-12
FI913169A (fi) 1992-01-03
ZA915056B (en) 1992-03-25
PT98169B (pt) 1998-12-31
FI104177B1 (fi) 1999-11-30
NO303018B1 (no) 1998-05-18
ES2099718T3 (es) 1997-06-01
HU215147B (hu) 2000-03-28
DE59108644D1 (de) 1997-05-07
NZ238769A (en) 1993-11-25
EP0464638B1 (de) 1997-04-02
CA2045891C (en) 2003-07-22
GR3023432T3 (en) 1997-08-29
FI913169A0 (fi) 1991-06-28
AU7947591A (en) 1992-01-02
KR100200400B1 (ko) 1999-06-15
AU647143B2 (en) 1994-03-17
NO912585D0 (no) 1991-07-01
JP3186795B2 (ja) 2001-07-11
HUT62010A (en) 1993-03-29
IE912309A1 (en) 1992-01-15
JPH05222088A (ja) 1993-08-31

Similar Documents

Publication Publication Date Title
ATE151076T1 (de) Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen
DE69004712T2 (de) Verfahren zur Herstellung von Polybutadien mit verbesserter Verarbeitkeit.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
DE3786319T2 (de) Verfahren zur Herstellung von Polyisobutylen mit Allyl-Endgruppen.
DE3887625T2 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3853060D1 (de) Verfahren zur Herstellung von Oligonucleotiden.
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
DE68910813T2 (de) Verfahren zur Stabilisierung von elektroaktiven Polymerelektroden.
IT1226123B (it) Turbopompa molecolare.
DE3871272D1 (de) Oberflaechenbehandlung von polyolefinformkoerpern.
IT1197853B (it) Composti politriazinici contenenti gruppi piperidinilammidinici e loro impiego come stabilizzanti per polimeri
DE68913888T2 (de) Verfahren zur Herstellung von 3,5-dialkyl-4-hydroxybenzyl-substituierten Aromaten.
FI853708L (fi) Svaorantaendlig, biologiskt soenderfallande funktionell vaetska.
DE3881103T2 (de) Verfahren zur Herstellung von 1,3,2-Oxazaphosphorinan.
DE69126610T2 (de) Darstellung von 3,4,6-trifluorophthalsäure
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
Gharavi Molecular cloning of the human lipoxygenase gene
IT8619957A0 (it) Composizione profumata per il trattamento di articoli in pelle e cuoio.
ATE68122T1 (de) Herstellung von hohlen kunststoffartikeln.
ATE56913T1 (de) Herstellung von hohlen kunststoffartikeln.
DE68916026T2 (de) Herstellung von Mitteldestillaten.
DE69003400T2 (de) Verfahren zur Herstellung von 4,4' Dihydroxydiphenylsulfon.
ES536881A0 (es) Mejoras introducidas en el objeto de la patente de invencion n. 516325.
ATE53010T1 (de) Verfahren zur herstellung von 2,2,-dibrom-3oxonitrilen.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time